Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaoqian Li

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|April 12, 2022
Study on Multiple Fractal Analysis and Response Characteristics of Acoustic Emission Signals from Goaf Rock BodiesXuebin Xie, Shaoqian Li, Jiang Guo
Cardiovascular Diabetology|May 25, 2022
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus managementBo Xu, Shaoqian Li, Bo Kang, et al.
ISA Transactions|February 18, 2026
Fixed-time adaptive prescribed-performance sliding-mode control for space manipulators with actuator uncertaintiesSheng Gao, Wei Zhang, Shaoqian Li, et al.
The Annals of Pharmacotherapy|February 23, 2025
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-AnalysisBo Xu, Mingxia Yang, Shaoqian Li, et al.
Sensors (Basel, Switzerland)|January 23, 2024
A Precise and Stable Space-Based Time System for Navigation in Smart CitiesShaoqian Li, Baojun Lin, Rui Li, et al.
Blood Reviews|May 29, 2024
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuriaBo Xu, Bo Kang, Jixiang Chen, et al.
International Journal of Clinical Pharmacy|April 28, 2025
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trialsBo Xu, Bo Kang, Shaoqian Li, et al.
Investigational New Drugs|September 8, 2022
CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphomaBo Xu, Shaoqian Li, Bo Kang, et al.
Cardiovascular Drugs and Therapy|December 4, 2024
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting SystemBo Xu, Tianqiao Zhang, Bo Kang, et al.
Molecular Biology Reports|April 3, 2022
Genome-wide identification of PEBP gene family members in potato, their phylogenetic relationships, and expression patterns under heat stressGuodong Zhang, Xin Jin, Xiubao Li, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|April 12, 2022
Study on Multiple Fractal Analysis and Response Characteristics of Acoustic Emission Signals from Goaf Rock BodiesXuebin Xie, Shaoqian Li, Jiang Guo
Cardiovascular Diabetology|May 25, 2022
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus managementBo Xu, Shaoqian Li, Bo Kang, et al.
ISA Transactions|February 18, 2026
Fixed-time adaptive prescribed-performance sliding-mode control for space manipulators with actuator uncertaintiesSheng Gao, Wei Zhang, Shaoqian Li, et al.
The Annals of Pharmacotherapy|February 23, 2025
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-AnalysisBo Xu, Mingxia Yang, Shaoqian Li, et al.
Sensors (Basel, Switzerland)|January 23, 2024
A Precise and Stable Space-Based Time System for Navigation in Smart CitiesShaoqian Li, Baojun Lin, Rui Li, et al.
Blood Reviews|May 29, 2024
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuriaBo Xu, Bo Kang, Jixiang Chen, et al.
International Journal of Clinical Pharmacy|April 28, 2025
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trialsBo Xu, Bo Kang, Shaoqian Li, et al.
Investigational New Drugs|September 8, 2022
CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphomaBo Xu, Shaoqian Li, Bo Kang, et al.
Cardiovascular Drugs and Therapy|December 4, 2024
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting SystemBo Xu, Tianqiao Zhang, Bo Kang, et al.
Molecular Biology Reports|April 3, 2022
Genome-wide identification of PEBP gene family members in potato, their phylogenetic relationships, and expression patterns under heat stressGuodong Zhang, Xin Jin, Xiubao Li, et al.
Pageof 2